Early Inhibition of Nitric Oxide Production Increases HSV-1 Intranasal Infection

Journal of Medical Virology

Volumn 73, Issue 2, 2004, Pages 313-322

  Gamba, Gisela ^a   Cavalieri, Hernan ^a   Courreges, Maria C ^a   Massouh, Ernesto J ^a   Benencia, Fabian ^a,b,c  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Aminoguanidine; HSV; Mice; Nitric oxide; NOS II

Indexed keywords

AMINOGUANIDINE; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOT HYBRIDIZATION; EYE INFECTION; FACIAL BONE; HERPES SIMPLEX VIRUS 1; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LUNG ALVEOLUS MACROPHAGE; LUNG INFECTION; LUNG PARENCHYMA; MALE; MOUSE; NEUTROPHIL; NONHUMAN; NOSE INFECTION; OXIDATIVE STRESS; RESPIRATORY TRACT INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRAIN IDENTIFICATION; VIRUS PNEUMONIA;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GUANIDINES; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; IMMUNOBLOTTING; LUNG; MALE; MICE; MICE, INBRED BALB C; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PNEUMONIA; PNEUMONIA, VIRAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL ANALYSIS; TURBINATES; VIRUS REPLICATION;

ANIMALIA; HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

EID: 2142810124     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20093     Document Type: Article

References (72)

1. Adler H, Beland JL, Del-Pan NC, Kobzik L, Brewer JP, Martin TR, Rimm IJ. 1997. Suppression of Herpes simplex virus type 1 (HSV-1)-induced pneumonia in mice by inhibition of inducible nitric oxide synthase (iNOS, NOS2). J Exp Med 185:1533-1540.
2. Adler H, Beland JL, Del-Pan NC, Kobzik L, Sobel RA, Rimm IJ. 1999. In the absence of T cells, natural killer cells protect from mortality due to HSV-1 encephalitis. J Neuroimmunol 93:208-213.
3. Akarid K, Sinet M, Desforges B, Gougerot-Pocidalo MA. 1995. Inhibitory effect of nitric oxide on the replication of a murine retrovirus in vitro and in vivo. J Virol 69:7001-7005.
4. Amaro MJ, Bartolome J, Pardo M, Cotonat T, Lopez-Farre A, Carreno V. 1997. Decreased nitric oxide production in chronic viral hepatitis B and C. J Med Virol 51:326-331.
5. Benencia F, Courreges MC. 1999. Nitric oxide and macrophage antiviral extrinsic activity. Immunology 98(3):363-370.
6. Benencia F, Courrèges MC, Gamba G, Cavalieri H, Massouh EJ. 2001. Aminoguanidine, a nitric oxide synthase inhibitor augments ocular infection with Herpes simplex virus in Balb/c mice. IOVS 42(6): 1277-1284.
7. Benencia F, Gamba G, Cavalieri H, Courreges MC, Benedetti R, Villamil SM, Massouh EJ. 2003. Nitric oxide and HSV vaginal infection in BALB/c mice. Virology 309(1):75-84.
8. Bernstein DI, Harrison CJ, Jenski LJ, Myers MG, Stanberry LR. 1991. Cell-mediated immunologic responses and recurrent genital Herpes in the guinea pig. J Immunol 146:3571-3577.
9. Bi Z, Reiss CS. 1995. Inhibition of vesicular stomatitis virus infection by nitric oxide. J Virol 69:2208-2213.
10. Bi Z, Barna M, Komatsu T, Reiss CS. 1995. Vesicular stomatitis virus infection of the central nervous system activates both innate and acquired immunity. J Virol 69:6466-6469.
11. Camazine B, Antkowiak JG, Nava MER, Lipman BJ, Takita H. 1995. Herpes simplex viral pneumonia in the postthoracotomy patient. Chest 108:876-879.
12. Cheng H, Tumpey TM, Staats HF, van Rooijen N, Oakes JE, Lausch RN. 2000. Role of macrophages in restricting herpes simplex virus type 1 growth after ocular infection. IOVS 41:1402-1409.
13. Cherr GS, Meredith JW, Chang M. 2000. Herpes simplex virus pneumonia in trauma patients. J Trauma 49:547-549.
14. Choi DW. 1993. Nitric oxide: Foe or friend to the injured brain? PNAS 90:9741-9743.
15. Daheshia M, Kanangat S, Rouse BT. 1998. Production of key molecules by ocular neutrophils early after herpetic infection of the cornea. Exp Eye Res 67(6):619-624.
16. Daheshia M, Deshpande S, Chun S, Kuklin NA, Rouse BT. 1999. Resistance to herpetic stromal keratitis in immunized B-cell-deficient mice. Virology 257:168-176.
17. Ding AH, Nathan CF, Stuehr DJ. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. J Immunol 141:2407-2412.
18. Drummond CW, Eglin RP, Esiri MM. 1994. Herpes simplex virus encephalitis in a mouse model: PCR evidence for CNS latency following acute infection. J Neurol Sci 127:159-163.
19. Erlich KS, Dix RD, Mills J. 1987. Prevention and treatment of experimental herpes simplex virus encephalitis with human immune serum globulin. Antimicrob Agents Chemother 31:1006-1009.
20. Erlich KS, Wofsy D, Dix RD, Mills J. 1989. Effects of selective depletion of L3T4+ T-lymphocytes on herpes simplex virus encephalitis. Clin Immunol Immunopathol 52:190-201.
21. Feldman S, Stokes DC. 1987. Varicella zoster and herpes simplex virus pneumonia. Semin Respir Infect 2:84-94.
22. Fuji S, Akaike T, Maeda H. 1999. Role of nitric oxide in pathogenesis of herpes simplex virus encephalitis in rats. Virology 256:203-212.
23. Gardiner SM, Kemp PA, March JE, Bennett T. 1996. Influence of aminoguanidine and the endothelin antagonist, SB 209670, on the regional haemodynamic effects of endotoxaemia in conscious rats. Br J Pharmacol 118(7):1822-1828.
24. Ghiasi H, Cai S, Perng GC, Nesburn AB, Wechsler SL. 2000. The role of natural killer cells in protection of mice against death and corneal scarring following ocular HSV-1 infection. Antivir Res 45:33-45.
25. Guc MO. 1999. Endotoxin-endothelium interactions in "low-perfusion state" research. J Physiol Pharmacol 50(4):541-550.
26. Guillemard E, Geniteau-Legendere M, Kergot R, Lemaire G, Petit JF, Labarre C, Quero AM. 1996. Activity of nitric oxide-generating compounds against encephalomyocarditis virus. Antimicrob Agents Chemother 40:1057-1063.
27. Haas J, Meyding-Lamade U, Fath A, Stingele K, Storch-Hagenlocher B, Wildemann B. 1999. Acyclovir treatment of experimentally induced herpes simplex virus encephalitis: Monitoring the changes in immunologic NO synthase expression and viral load within brain tissue of SJL mice. Neurosci Lett 264(1-3):129-132.
28. Harris N, Buller M, Karupiah G. 1995. Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication. J Virol 69:910-915.
29. Hiraoka Y, Kishimoto C, Takada H, Nakamura M, Kurokawa M, Ochiai H, Shiraki K. 1996. Nitric oxide and murine coxsackievirus B3 myocarditis: Aggravation of myocarditis by inhibition of nitric oxide synthase. J Am Coll Cardiol 28:1610-1615.
30. Karupiah G, Xie Q, Buller RML, Nathan C, Duiarte C, MacMicking JD. 1993. Inhibition of viral replication by interferon-7-induced nitric oxide synthase. Science 261:1445-1447.
31. Kern ER, Richards JT, Glasgow LA, Overall JC, Jr., de Miranda P. 1982. Optimal treatment of herpes simplex virus encephalitis in mice with oral acyclovir. Am J Med 73:125-131.
32. Kitabayashi A, Hirokawa M, Horiuchi T, Kawabata Y, Miura AB. 2000. Late-onset herpes simplex virus-associated interstitial pneumonia after allogeneic bone marrow transplantation. Bone Marrow Transplant 25:225-226.
33. Kodukula P, Liu T, Rooijen NV, Jager MJ, Hendricks RL. 1999. Macrophage control of herpes simplex virus type 1 replication in the peripheral nervous system. Immunology 162:2895-2905.
34. Lamade UM, Lamade W, Hess T, Gosztonyi G, Kehm R, Sartor K, Hacke W. 1996. A mouse model of herpes simplex virus encephalitis: Diagnostic brain imaging by magnetic resonance imaging. In Vivo 10:563-568.
35. Lane TE, Paoletti AD, Buchmeier MJ. 1997. Dissociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine coronavirus. J Virol 71:2202-2210.
36. Lecanu L, Margaill I, Boughali H, Cohen-Tenoudji B, Boulu RG, Plotkine M. 1998. Deleterious Ca-independent NOS activity after oxidative stress in rat striatum. Neuroreport 9(3):559-563.
37. Lin Y, Huang Y, Ma S, Yeh C, Chiou S, Chen L, Liao C. 1997. Inhibition of Japanese encephalitis virus infection by nitric oxide: Antiviral effect of nitric oxide on RNA virus replication. J Virol 71:5227-5232.
38. Liu T, Tang Q, Hendricks RL. 1996. Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection. J Virol 70(1):264-271.
39. Lowenstein CHJ, Hill SL, Lafond-Walker A, Wu J, Allen G, Landavere M, Rose NR, Herskowitz A. 1996. Nitric oxide inhibits viral replication in murine myocarditis. J Clin Invest 97:1837-1843.
40. MacMicking J, Xie Q, Nathan C. 1997. Nitric oxide and macrophage function. Ann Rev Immunol 15:323-350.
41. Manickan E, Rouse RJ, Yu Z, Wire WS, Rouse BT. 1995. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes. J Immunol 155:259-265.
42. Meyding-Lamade U, Lamade W, Kehm R, Knopf KW, Hess T, Gosztonyi G, Degen O, Hacke W. 1998. Herpes simplex virus encephalitis: Cranial magnetic resonance imaging and neuropathology in a mouse model. Neurosci Lett 248(1):13-16.
43. Meyding-Lamade U, Lamade W, Kehm R, Oberlinner C, Fath A, Wildemann B, Haas J, Hacke W. 1999. Herpes simplex virus encephalitis: Chronic progressive cerebral MRI changes despite good clinical recovery and low viral load-An experimental mouse study. Eur J Neurol 6(5):531-538.
44. Meyding-Lamade U, Seyfer S, Haas J, Dvorak F, Kehm R, Lamade W, Hacke W, Wildemann B. 2002. Experimental herpes simplex virus encephalitis: Inhibition of the expression of inducible nitric oxide synthase in mouse brain tissue. Neurosci Lett 318(1):21-24.
45. Meyding-Lamade UK, Oberlinner C, Rau PR, Seyfer S, Heiland S, Sellner J, Wildemann BT, Lamade WR. 2003. Experimental herpes simplex virus encephalitis: A combination therapy of acyclovir and glucocorticoids reduces long-term magnetic resonance imaging abnormalities. J Neurovirol 9(1):118-125.
46. Mikami S, Kawashima S, Kanazawa K, Hirata K, Katayama Y, Hotta H, Hayashi Y, Ito H, Yokoyama M. 1996. Expression of nitric oxide synthase in a murine model of viral myocarditis induced by coxsackievirus B3. Biochem Biophys Res Comm 220:983-989.
47. Milligan GN, Bernstein DI. 1995a. Analysis of Herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2. Virology 212:481-489.
48. Milligan GN, Bernstein DI. 1995b. Generation of humoral immune responses against herpes simplex virus type 2 in the murine female genital tract. Virology 206:234-241.
49. Milligan GN, Bernstein DI, Bourne N. 1998. T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2. J Immunol 160:6093-6100.
50. Milligan GN, Bourne N, Dudley KL. 2001. Role of polymorphonuclear leukocytes in resolution of HSV-2 infection of the mouse vagina. J Reprod Immunol 49:49-56.
51. Miyazato A, Kishimoto H, Tamaki K, Nakama K, Saito A. 2001. Herpes simplex virus bronchopneumonia in a non-immunocompromized individual. Inter Med 40:836-840.
52. Nass PH, Elkins KL, Weir JP. 2001. Protective immunity against herpes simplex virus generated by DNA vaccination compared to natural infection. Vaccine 19:1538-1546.
53. Nathan C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J 6:3051-3064.
54. Neufeld AH, Sawada A, Becker B. 1999. Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc Natl Acad Sci USA 96(17):9944-9948.
55. Neufeld AH, Kawai S, Das S, Vora S, Gachie E, Connor JR, Manning PT. 2002. Loss of retinal ganglion cells following retinal ischemia: The role of inducible nitric oxide synthase. Exp Eye Res 75(5): 521-528.
56. Oakes JE, Monteiro CA, Cubitt CL, Lausch RN. 1993. Induction of interleukin-8 gene expression is associated with herpes simplex virus infection of human corneal keratocytes but not human corneal epithelial cells. J Virol 67(8):4777-4784.
57. Pertile TL. 1996. An antiviral effect of nitric oxide: Inhibition of reovirus replication. Avian Dis 40:342-348.
58. Roizman B. 1996. The function of herpes simplex virus genes: A primer for genetic engineering of novel vectors. PNAS 93:11307-11312.
59. Ruuls SR, Van Der Linden S, Sontrop K, Huitinga I, Dijkstra CD. 1996. Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors. Clin Exp Immunol 103:467-474.
60. Sato E, Simpson KL, Grisham MB, Koyama S, Robbins RA. 2000a. Reactive nitrogen and oxygen species attenuate interleukin-8 induced neutrophil chemotactic activity in vitro. J Biol Chem 275(15):10826-10830.
61. Sato E, Simpson KL, Grisham MB, Koyama S, Robbins RA. 2000b. Inhibition of MIP-1 alpha-induced human neutrophil and monocyte hemotactic activity by reactive oxygen and nitrogen metabolites. J Lab Clin Med 135(2):161-169.
62. Schmandra TC, Folz IC, Kimpel M, Fleming I, Holzer K, Hanisch EW. 2001. Cirrhosis serum induces a nitric oxide-associated vascular hyporeactivity of aortic segments from healthy rats in vitro. Eur J Gastroenterol Hepatol 13(8):957-962.
63. Schuller D, Spessert C, Fraser VJ. 1993. Herpes simplex virus from respiratory tract secretions: Epidemiology, clinical characteristics, and outcome in immunocompromised and nonimmunocompromised hosts. Amer J Med 94:29-33.
64. Shimokawa S, Watanabe S, Taira A, Eizuru Y. 2001. Herpes simplex virus pneumonia after cardiac surgery: Report of a case. Surg Today 31:814-816.
65. Smyth RL, Higenbottam TW, Scott JP, Wreighitt TG, Stewart S, Clelland CA, McGoldrick JP, Wallwork J. 1990. Herpes simplex virus infection in heart-lung transplant recipients. Transplant 49:735-739.
66. Stuehr DJ, Nathan CF. 1989. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 5:1543-1555.
67. Su SH, Chen H, Jen CJ. 2001. C57BL/6 and BALB/c bronchoalveolar macrophages respond differently to exercise. J Immunol 167(9): 5084-5091.
68. Taplitz RA, Jordan MC. 2002. Pneumonia caused by herpesviruses in recipients of hematopoietic cell transplants. Semin Res Infect 17: 121-129.
69. Thomas J, Kanangat S, Rouse BT. 1998. Herpes simplex virus replication-induced expression of chemokines and proinflammatory cytokines in the eye: Implications in herpetic stromal keratitis. J Interfer Cytok Res 18:681-690.
70. Tuxen DV, Wilson JW, Cade JJ. 1987. Prevention of lower respiratory Herpes simplex virus infection with acyclovir in patients with the adult respiratory distress syndrome. Am Rev Res Dis 136:402-405.
71. Watanabe D, Adachi A, Tomita Y, Yamamoto M, Kobayashi M, Nishiyama Y. 1999. The role of polymorphonuclear leukocyte infiltration in herpes simplex virus infection of murine skin. Arch Dermatol Res 291(1):28-36.
72. Zhang P, Bagby GJ, Kolls JK, Welsh DA, Summer WR, Andresen J, Nelson S. 2001. The effects of granulocyte colony-stimulating factor and neutrophil recruitment on the pulmonary chemokine response to intratracheal endotoxin. J Immunol 166(1):458-465.